Fintel · Sep 5, 2026
NV
NYSE · NVST
Envista Holdings Corp
Healthcare · Medical - Equipment & Services
$25.87
Down-$0.55 (-2.08%)
Updated Sep 11, 2026, 3:05 AM
SID Score
4.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.64B
- P/E ratio
- 244.84
- Dividend yield
- 0.00%
- 52-week range
- $22.36 – $29.53
- Volume
- 2.22M
- Avg. volume
- 2.08M
Price performance
NVST price history
1M range · 20 trading sessions · Daily adjusted prices
NVST closed at $25.87 after 20 trading sessions, down 7.87% for the selected period.
- Last close
- $25.87
- Period change
- -7.87%
- Period low
- $25.87
- Period high
- $28.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $26.13 | $26.41 | $25.735 | $25.87 | 2.22M |
| Sep 9, 2026 | $26.60 | $26.96 | $26.36 | $26.42 | 1.89M |
| Sep 8, 2026 | $27.10 | $27.35 | $26.67 | $26.81 | 2.48M |
| Sep 4, 2026 | $27.30 | $27.51 | $27.015 | $27.28 | 1.68M |
| Sep 3, 2026 | $28.27 | $28.27 | $27.205 | $27.59 | 2.33M |
| Sep 2, 2026 | $26.72 | $27.635 | $26.645 | $27.39 | 1.76M |
| Sep 1, 2026 | $27.21 | $27.61 | $26.595 | $26.64 | 2.17M |
| Aug 31, 2026 | $26.88 | $27.29 | $26.69 | $27.14 | 1.48M |
| Aug 28, 2026 | $27.41 | $27.56 | $27.08 | $27.13 | 1.21M |
| Aug 27, 2026 | $27.72 | $27.985 | $27.35 | $27.44 | 1.45M |
| Aug 26, 2026 | $27.41 | $28.11 | $27.335 | $27.80 | 1.52M |
| Aug 25, 2026 | $27.22 | $27.58 | $26.68 | $27.47 | 2.54M |
| Aug 24, 2026 | $27.21 | $28.0079 | $27.10 | $27.34 | 1.79M |
| Aug 21, 2026 | $27.00 | $27.235 | $26.785 | $27.20 | 2.01M |
| Aug 20, 2026 | $27.25 | $27.665 | $26.925 | $26.93 | 1.92M |
| Aug 19, 2026 | $28.09 | $28.87 | $27.50 | $27.58 | 3.21M |
| Aug 18, 2026 | $27.77 | $28.49 | $27.50 | $27.82 | 2.82M |
| Aug 17, 2026 | $27.66 | $27.98 | $27.336 | $27.64 | 2.84M |
| Aug 14, 2026 | $28.00 | $28.42 | $27.925 | $28.07 | 2.53M |
| Aug 13, 2026 | $28.90 | $29.00 | $27.87 | $28.08 | 2.65M |
Latest NVST news
The latest Smart Investors Daily articles mentioning NVST.
Stock researchCompany · Overview
NVST research
Overview
Company profile and research snapshot.
Company profile
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $24.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Piper Sandler | Neutral | — |
| Jul 29, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 11, 2026 | Barclays | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 3, 2026
JP Morgan Upgrades Envista Holdings to Overweight, Raises Price Target to $32
JP Morgan analyst Lilia-Celine Lozada upgrades Envista Holdings (NYSE:NVST) from Neutral to Overweight and raises the price target from $29 to $32.
Yahoo · Sep 3, 2026
Envista Holdings Shares Rise After JPMorgan Upgrade
Envista Holdings Corp. (NYSE:NVST) shares rose 2.
Yahoo · Sep 1, 2026
Medtronic Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
MDT beats Q1 earnings and revenue estimates as broad-based growth drives shares higher and prompts a fiscal 2027 guidance boost.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
